Glaxo’s Revolutionary Lupus Treatment Benlysta Now EU Approved

The first treatment developed for lupus in over 50 years has finally been approved by the European Union this week. The watchdog, European Medicines Agency, has backed the injectable drug that will cost Europeans $23,000 USD a year. Already approved in the United States in March 2011, the drug costs Americans $35,000 USD annually. Benlysta’s annual global sales are expected to reach $3…


Comments are closed.